Skip to main content
Erschienen in: Journal of Neuro-Oncology 1/2012

01.05.2012 | Clinical Study

Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery

verfasst von: Albert Attia, Michael D. Chan, Ryan T. Mott, Greg B. Russell, David Seif, J. Daniel Bourland, Allan F. Deguzman, Thomas L. Ellis, Kevin P. McMullen, Michael T. Munley, Stephen B. Tatter, Edward G. Shaw

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Atypical meningiomas have poor local control with emerging literature indicating the use of radiosurgery in treatment. The purpose of this study was to evaluate clinical outcomes including local control and failure pattern after Gamma Knife radiosurgery (GKRS) and factors that may affect these outcomes. Between 1999 and 2008, 24 patients were treated with GKRS as either primary or salvage treatment for pathologically proven atypical meningiomas. Treatment failures were determined by serial magnetic resonance imaging. A median marginal dose of 14 Gy was used (range 10.5–18 Gy). Overall local control rates at 1, 2, and 5 years were 75, 51, and 44%, respectively. With median follow-up time of 42.5 months, 14 of 24 patients experienced a treatment failure at time of last follow-up. Eight recurrences were in-field, four were marginal failures, and two were distant failures. Wilcoxon analysis revealed that the conformality index (CI) was a significant predictor of local recurrence (P = 0.04). CI did not predict for distant recurrences (P = 0.16). On multivariate analysis evaluating factors predicting progression free survival, dose >14 Gy was found to be statistically significant (P = 0.01). There appears to be a dose response using GKRS beyond 14 Gy but given the suboptimal local control rates in this study, higher doses may still be needed to obtain better local control.
Literatur
2.
Zurück zum Zitat Jaaskelainen J (1986) Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:461–469PubMedCrossRef Jaaskelainen J (1986) Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:461–469PubMedCrossRef
3.
Zurück zum Zitat Harris AE, Lee JY, Omalu B, Flickinger JC, Kondziolka D, Lunsford LD (2003) The effect of radiosurgery during management of aggressive meningiomas. Surg Neurol 60:298–305 (discussion 305)PubMedCrossRef Harris AE, Lee JY, Omalu B, Flickinger JC, Kondziolka D, Lunsford LD (2003) The effect of radiosurgery during management of aggressive meningiomas. Surg Neurol 60:298–305 (discussion 305)PubMedCrossRef
4.
Zurück zum Zitat Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH (2000) Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys 46:57–61PubMedCrossRef Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH (2000) Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys 46:57–61PubMedCrossRef
5.
Zurück zum Zitat Hug EB, Devries A, Thornton AF et al (2000) Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48:151–160PubMedCrossRef Hug EB, Devries A, Thornton AF et al (2000) Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48:151–160PubMedCrossRef
6.
Zurück zum Zitat Kano H, Takahashi JA, Katsuki T et al (2007) Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol 84:41–47PubMedCrossRef Kano H, Takahashi JA, Katsuki T et al (2007) Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol 84:41–47PubMedCrossRef
7.
Zurück zum Zitat Winkler C, Dornfeld S, Schwarz R, Friedrich S, Baumann M (1998) The results of radiotherapy in meningiomas with a high risk of recurrence. A retrospective analysis. Strahlenther Onkol 174:624–628PubMedCrossRef Winkler C, Dornfeld S, Schwarz R, Friedrich S, Baumann M (1998) The results of radiotherapy in meningiomas with a high risk of recurrence. A retrospective analysis. Strahlenther Onkol 174:624–628PubMedCrossRef
8.
Zurück zum Zitat Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL (1997) Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39:427–436PubMedCrossRef Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL (1997) Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39:427–436PubMedCrossRef
9.
Zurück zum Zitat Stafford SL, Pollock BE, Foote RL et al (2001) Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 49:1029–1037 (discussion 1027–1037)PubMed Stafford SL, Pollock BE, Foote RL et al (2001) Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 49:1029–1037 (discussion 1027–1037)PubMed
10.
Zurück zum Zitat Hakim R, Alexander E III, Loeffler JS et al (1998) Results of linear accelerator-based radiosurgery for intracranial meningiomas. Neurosurgery 42:446–453 (discussion 444–453)PubMedCrossRef Hakim R, Alexander E III, Loeffler JS et al (1998) Results of linear accelerator-based radiosurgery for intracranial meningiomas. Neurosurgery 42:446–453 (discussion 444–453)PubMedCrossRef
11.
Zurück zum Zitat Huffmann BC, Reinacher PC, Gilsbach JM (2005) Gamma knife surgery for atypical meningiomas. J Neurosurg 102(Suppl):283–286PubMedCrossRef Huffmann BC, Reinacher PC, Gilsbach JM (2005) Gamma knife surgery for atypical meningiomas. J Neurosurg 102(Suppl):283–286PubMedCrossRef
12.
Zurück zum Zitat Ojemann SG, Sneed PK, Larson DA et al (2000) Radiosurgery for malignant meningioma: results in 22 patients. J Neurosurg 93(Suppl 3):62–67PubMed Ojemann SG, Sneed PK, Larson DA et al (2000) Radiosurgery for malignant meningioma: results in 22 patients. J Neurosurg 93(Suppl 3):62–67PubMed
13.
Zurück zum Zitat Henzel M, Gross MW, Hamm K et al (2006) Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity. Strahlenther Onkol 182:382–388PubMedCrossRef Henzel M, Gross MW, Hamm K et al (2006) Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity. Strahlenther Onkol 182:382–388PubMedCrossRef
14.
Zurück zum Zitat Debus J, Wuendrich M, Pirzkall A et al (2001) High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol 19:3547–3553PubMed Debus J, Wuendrich M, Pirzkall A et al (2001) High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol 19:3547–3553PubMed
15.
Zurück zum Zitat Boskos C, Feuvret L, Noel G et al (2009) Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys 75:399–406PubMedCrossRef Boskos C, Feuvret L, Noel G et al (2009) Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys 75:399–406PubMedCrossRef
16.
Zurück zum Zitat Pasquier D, Bijmolt S, Veninga T et al (2008) Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys 71:1388–1393PubMedCrossRef Pasquier D, Bijmolt S, Veninga T et al (2008) Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys 71:1388–1393PubMedCrossRef
17.
Zurück zum Zitat Kondziolka D, Lunsford LD, McLaughlin MR, Flickinger JC (1998) Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 339:1426–1433PubMedCrossRef Kondziolka D, Lunsford LD, McLaughlin MR, Flickinger JC (1998) Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 339:1426–1433PubMedCrossRef
18.
Zurück zum Zitat Kondziolka D, Mathieu D, Lunsford LD et al (2008) Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 62:53–58 (discussion 58–60)PubMedCrossRef Kondziolka D, Mathieu D, Lunsford LD et al (2008) Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 62:53–58 (discussion 58–60)PubMedCrossRef
19.
Zurück zum Zitat Shaw E, Scott C, Souhami L et al (1996) Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys 34:647–654PubMedCrossRef Shaw E, Scott C, Souhami L et al (1996) Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys 34:647–654PubMedCrossRef
20.
Zurück zum Zitat Pavy JJ, Denekamp J, Letschert J et al (1995) EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35:11–15PubMedCrossRef Pavy JJ, Denekamp J, Letschert J et al (1995) EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35:11–15PubMedCrossRef
21.
Zurück zum Zitat Aghi MK, Carter BS, Cosgrove GR et al (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56–60 (discussion 60)PubMedCrossRef Aghi MK, Carter BS, Cosgrove GR et al (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56–60 (discussion 60)PubMedCrossRef
22.
Zurück zum Zitat Goldsmith BJ, Wara WM, Wilson CB, Larson DA (1994) Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80:195–201PubMedCrossRef Goldsmith BJ, Wara WM, Wilson CB, Larson DA (1994) Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80:195–201PubMedCrossRef
23.
Zurück zum Zitat Ganz JC, Backlund EO, Thorsen FA (1993) The results of gamma knife surgery of meningiomas, related to size of tumor and dose. Stereotact Funct Neurosurg 61(Suppl 1):23–29PubMedCrossRef Ganz JC, Backlund EO, Thorsen FA (1993) The results of gamma knife surgery of meningiomas, related to size of tumor and dose. Stereotact Funct Neurosurg 61(Suppl 1):23–29PubMedCrossRef
Metadaten
Titel
Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery
verfasst von
Albert Attia
Michael D. Chan
Ryan T. Mott
Greg B. Russell
David Seif
J. Daniel Bourland
Allan F. Deguzman
Thomas L. Ellis
Kevin P. McMullen
Michael T. Munley
Stephen B. Tatter
Edward G. Shaw
Publikationsdatum
01.05.2012
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 1/2012
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-012-0828-1

Weitere Artikel der Ausgabe 1/2012

Journal of Neuro-Oncology 1/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.